
Mansour Oveissi
Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )
| Most Active Art Unit | 2415 |
| Art Unit(s) | 2616, 2464, 2415, 2416 |
| Total Applications | 1005 |
| Issued Applications | 795 |
| Pending Applications | 89 |
| Abandoned Applications | 156 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17910378
[patent_doc_number] => 20220312772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => MICROBIAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/625451
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625451 | MICROBIAL COMPOSITIONS | Jul 9, 2020 | Pending |
Array
(
[id] => 17168712
[patent_doc_number] => 20210322382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/892218
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892218 | METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF SINUS DISEASE | Jun 2, 2020 | Abandoned |
Array
(
[id] => 20212038
[patent_doc_number] => 12408668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Stable microbicide composition
[patent_app_type] => utility
[patent_app_number] => 17/615694
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1088
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615694 | Stable microbicide composition | Jun 1, 2020 | Issued |
Array
(
[id] => 20212038
[patent_doc_number] => 12408668
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Stable microbicide composition
[patent_app_type] => utility
[patent_app_number] => 17/615694
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1088
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615694 | Stable microbicide composition | Jun 1, 2020 | Issued |
Array
(
[id] => 18232090
[patent_doc_number] => 11596634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Lamotrigine oral liquid suspension and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/929929
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10084
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15929929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/929929 | Lamotrigine oral liquid suspension and use thereof | May 28, 2020 | Issued |
Array
(
[id] => 20076247
[patent_doc_number] => 12350281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Long-acting injectable formulations and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/879626
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4908
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879626 | Long-acting injectable formulations and use thereof | May 19, 2020 | Issued |
Array
(
[id] => 18127907
[patent_doc_number] => 11554102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
[patent_app_type] => utility
[patent_app_number] => 15/930295
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17150
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930295 | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders | May 11, 2020 | Issued |
Array
(
[id] => 18947068
[patent_doc_number] => 11890341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Compositions and methods for treating biofilm-related lung conditions
[patent_app_type] => utility
[patent_app_number] => 16/871504
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9945
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871504 | Compositions and methods for treating biofilm-related lung conditions | May 10, 2020 | Issued |
Array
(
[id] => 18013288
[patent_doc_number] => 11505570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Organic acid salt of nicotinamide riboside, composition including organic acid salt, and preparation methods of organic acid salt and composition
[patent_app_type] => utility
[patent_app_number] => 17/595192
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4455
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595192 | Organic acid salt of nicotinamide riboside, composition including organic acid salt, and preparation methods of organic acid salt and composition | May 10, 2020 | Issued |
Array
(
[id] => 17718321
[patent_doc_number] => 20220211040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => HIGH SPREADING ULV FORMULATIONS FOR INSECTICIDES
[patent_app_type] => utility
[patent_app_number] => 17/595082
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595082 | HIGH SPREADING ULV FORMULATIONS FOR INSECTICIDES | May 7, 2020 | Pending |
Array
(
[id] => 17422391
[patent_doc_number] => 11255838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
[patent_app_type] => utility
[patent_app_number] => 16/865064
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11436
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865064 | Levels, functions, and resistances related to chronic conditions by using lysine-based supplements | Apr 30, 2020 | Issued |
Array
(
[id] => 16420607
[patent_doc_number] => 20200345805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE
[patent_app_type] => utility
[patent_app_number] => 16/854818
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854818 | COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE | Apr 20, 2020 | Abandoned |
Array
(
[id] => 16504672
[patent_doc_number] => 20200383928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => BIODEGRADABLE EXTENDED RELEASE MICROSPHERE-HYDROGEL OCULAR DRUG DELIVERY SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/845184
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845184 | Biodegradable extended release microsphere-hydrogel ocular drug delivery system and method | Apr 9, 2020 | Issued |
Array
(
[id] => 16174736
[patent_doc_number] => 20200221704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT
[patent_app_type] => utility
[patent_app_number] => 16/833695
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833695
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833695 | METHOD FOR PRODUCING A PLANT LIFE ENHANCING PRODUCT | Mar 29, 2020 | Abandoned |
Array
(
[id] => 18353967
[patent_doc_number] => 11642351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Eslicarbazepine suspension
[patent_app_type] => utility
[patent_app_number] => 16/827534
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6978
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827534 | Eslicarbazepine suspension | Mar 22, 2020 | Issued |
Array
(
[id] => 18792695
[patent_doc_number] => 11826429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Pharmaceutical composition comprising brinzolamide
[patent_app_type] => utility
[patent_app_number] => 16/811674
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9655
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811674 | Pharmaceutical composition comprising brinzolamide | Mar 5, 2020 | Issued |
Array
(
[id] => 16086847
[patent_doc_number] => 20200197410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => D2O STABILIZED PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/805612
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805612
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805612 | D2O stabilized pharmaceutical formulations | Feb 27, 2020 | Issued |
Array
(
[id] => 16266486
[patent_doc_number] => 20200267973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ALKALINE DISINFECTING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/796990
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796990 | ALKALINE DISINFECTING COMPOSITIONS | Feb 20, 2020 | Pending |
Array
(
[id] => 20385425
[patent_doc_number] => 12485134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
[patent_app_type] => utility
[patent_app_number] => 16/798207
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 30
[patent_no_of_words] => 27281
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798207 | Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations | Feb 20, 2020 | Issued |
Array
(
[id] => 16435578
[patent_doc_number] => 20200352903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => Choline Esters
[patent_app_type] => utility
[patent_app_number] => 16/791265
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791265 | Choline Esters | Feb 13, 2020 | Abandoned |